CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 7, 2009--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by JPMorgan on Wednesday, January 14,
2009 at 12:30 p.m. EST (9:30 a.m. PST). David Broecker, CEO of Alkermes,
will provide a strategic overview of the company and present the
company's corporate goals for calendar 2009. The presentation will be
webcast from the Westin St. Francis Hotel in San Francisco, California
and may be accessed under the investor relations tab at www.alkermes.com.
The presentation will be archived for 30 days.
Alkermes, Inc. is a fully integrated biotechnology company committed to
developing innovative medicines to improve patients' lives. Alkermes
developed, manufactures and commercializes VIVITROL(R) for
alcohol dependence and manufactures RISPERDAL(R) CONSTA(R) for
schizophrenia. Alkermes' robust pipeline includes extended-release
injectable, pulmonary and oral products for the treatment of prevalent,
chronic diseases, such as central nervous system disorders, addiction
and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has
research facilities in Massachusetts and a commercial manufacturing
facility in Ohio.
CONTACT:
Alkermes, Inc.
Eva Stroynowski
617-583-6823
Corporate Communications
Source:
Alkermes, Inc.
